Research & Development
FDA clears Scopio Labs hematology analysis platform
Tel Aviv, Israel-based Scopio said the X100HT is a full-field digital imaging and artificial intelligence (AI)-enabled platform that combines high throughput with high resolution for hematological analysis.
June 9, 2022
Accumen launches crisis readiness survey
Accumen's National Health System Crisis Readiness Survey is designed to assess operational strengths and weaknesses of healthcare providers when it comes to crisis preparedness. The survey will include U.S. clinical labs, lab outreach, patient blood management, anemia management, radiology, and data departments across hospitals and health systems.
June 28, 2020
Top 10 product news stories for 2019
In fact, there were hundreds of developments in IVD testing in 2019 and selecting just 10 is a big challenge. But based on its decades of assessing and forecasting the market Kalorama Information selected the news items below as highly significant from the point of view of product advances.
December 23, 2019
Sysmex drives Clinical Lab 2.0 anemia project
Clinical Lab 2.0 is backed by the Project Santa Fe Foundation, which was founded in 2016 by Geisinger Health, the Henry Ford Health System, Northwell Health, and TriCore Reference Laboratories. The initiative supports multi-institutional demonstration projects that show the value of lab diagnostics to reduce healthcare costs on a global scale.
September 15, 2019
EKF flags use of handheld hemoglobin test in Africa
A group of nursing students from the Eleanor Mann School of Nursing at the University of Arkansas will use the handheld hemoglobin analyzer for people who live in small, remote villages in Ghana, where anemia is a high-risk condition that can be life-threatening.
May 19, 2019
Genetic causes identified for three rare diseases
Researchers in study validate test to identify newborns with homocystinuria, a rare inherited disease
SARS-CoV-2 infection weakens immune-cell response to vaccination, study suggests
Duke University researchers discover biomarkers may identify early pancreatic cancer risk
Werfen completes $2B acquisition of Immucor, expands presence in specialized diagnostics
Chembio CEO urges stockholders to tender remaining shares as deadline is extended for acquisition
Page 1 of 1